Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma: A Plea for Systematic Measurement of Growth Rates
The DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Supratentorial hemispheric diffuse low-grade gliomas (LGGs), i.e., World Health Organization grade II gliomas, are a heterogeneous group of tumors. During their natural course, LGGs tend to progress to a higher grade of malignancy, leading to neurological disability and ultimately to death. In this review, we will show, that during their low-grade period, these tumors exhibit systematically a spontaneous and continuous radiological growth, whatever their histological subtypes. The radiological tumor growth is easily quantified by measuring the evolution of the equivalent tumor diameter (calculated from the tumor volume), obtaining the velocity of diametric expansion (VDE). The spontaneous VDE of LGGs varies markedly with an average VDE of about 4 mm/year. It depends on intrinsic factors (1p19q codeletion status, P53 overexpression status) and can be modified by extrinsic factors (pregnancy). The spontaneous VDE carries a strong prognostic significance regarding progression-free and overall survivals. As a consequence, VDE should be integrated along with the other "static" parameters (multimodal imaging, histological and molecular analyses) in the initial investigations. In addition, the assessment of VDE obtained before, during, and after a particular oncological treatment helps in analyzing their effects on LGGs on an individual basis, helping to guide the decision making.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“VDE, the rate of change in tumor diameter over time, is an independent predictor of outcome in LGGs [43,44,45].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [45]
Citations
Cites
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
Sanai, N., & Berger, M. S. (2008) · Neurosurgery · doi:10.1227/01.neu.0000318159.21731.cf · Cited by 1,328
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Law, M., Yang, S., Wang, H., Babb, J. S., Johnson, G., Cha, S., Knopp, E. A., & Zagzag, D. (2003) · PubMed Central · Cited by 1,084
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms
Kelly, P. J., Daumas-Duport, C., Kispert, D. B., Kall, B. A., Scheithauer, B. W., & Illig, J. J. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.66.6.0865 · Cited by 798
Duffau, H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70140-x · Cited by 683
Self-citationMcGirt, M. J., Chaichana, K. L., Attenello, F. J., Weingart, J. D., Than, K., Burger, P. C., Olivi, A., Brem, H., & Quinoñes-Hinojosa, A. (2008) · Neurosurgery · doi:10.1227/01.neu.0000325729.41085.73 · Cited by 533
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
Soffietti, R., Baumert, B. G., Bello, L., Von Deimling, A., Duffau, H., Frénay, M., Grisold, W., Grant, R., Graus, F., Hoang‐Xuan, K., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03151.x · Cited by 505
Self-citationContinuous growth of mean tumor diameter in a subset of grade II gliomas
Mandonnet, E., Delattre, J., Tanguy, M., Swanson, K. R., Carpentier, A. F., Duffau, H., Cornu, P., Van Effenterre, R., Alvord, E. C., & Capelle, L. (2003) · Annals of Neurology · doi:10.1002/ana.10528 · Cited by 493
Self-citationThe Evolution of Mathematical Modeling of Glioma Proliferation and Invasion
Harpold, H. L. P., Alvord, E. C., & Swanson, K. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d9000 · Cited by 314
Cited by
Epileptic seizures in diffuse low-grade gliomas in adults
Pallud, J., Audureau, E., Blonski, M., Sanai, N., Bauchet, L., Fontaine, D., Mandonnet, E., Dezamis, E., Psimaras, D., Guyotat, J., et al. (2014) · Brain · doi:10.1093/brain/awt345 · Cited by 380
“…versus presence), spontaneous imaging tumour growth (velocity of diametric expansion on MRI as a continuous or binary variable, 5 or 58 mm/year; Pallud et al., 2006, 2012), tumour cystic component (presence versus absence), proliferation rates (cut-off at 5%), and biomolecular markers (1p19q…”
BackgroundSelf-citationIvosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
Mellinghoff, I. K., Ellingson, B. M., Touat, M., Maher, E., De La Fuente, M. I., Holdhoff, M., Cote, G. M., Burris, H., Janku, F., Young, R. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03327 · Cited by 324
“Brain magnetic resonance imaging (MRI) plays a central role in disease monitoring.(6,7) Malignant transformation of LGGs is often associated with the appearance of contrast enhancement.”
BackgroundDuffau, H., & Mandonnet, E. (2013) · Acta Neurochirurgica · doi:10.1007/s00701-013-1653-9 · Cited by 250
Self-citationVelocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas
Pallud, J., Blonski, M., Mandonnet, E., Audureau, E., Fontaine, D., Sanai, N., Bauchet, L., Peruzzi, P., Frénay, M., Colin, P., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos331 · Cited by 173
Self-citationInter-rater agreement in glioma segmentations on longitudinal MRI
Visser, M., Müller, D. M. J., van Duijn, R. J. M., Smits, M., Verburg, N., Hendriks, E. J., Nabuurs, R. J. A., Bot, J. C. J., Eijgelaar, R. S., Witte, M., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101727 · Cited by 126
“…2008), quantification of the effects of (pharmacological) interventions (Ben Abdallah et al., 2018b; Mandonnet et al., 2010; Pallud et al., 2012a; Pallud et al., 2012b), and statistical maps of care (De Witt Hamer et al., 2013; Mandonnet et al., 2007) and disease mechanisms (Amelot et al., 2017;…”
Background
Metadata
- Authors
- Pallud, J., Taillandier, L., Capelle, L., Fontaine, D., Peyre, M., Ducray, F., Duffau, H., & Mandonnet, E.
- Affiliations
- Hôpital Beaujon (FR)
- Université Paris Descartes (FR)
- Corresponding author
- Pallud, Johan
- Peyre, Matthieu
- Mandonnet, Emmanuel
- ORCID
- Venue
- Neurosurgery
- Published
- 2012-09
- Volume
- 71
- Issue
- 3
- Pages
- 729-740
- ISSN
- 0148-396X (ISSN-L)
- OpenAlex
- W2092864060
- Cited by
- 135
- References
- 53
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 4 · 2020: 15 · 2019: 5 · 2018: 6 · 2017: 18 · 2016: 6 · 2015: 12 · 2014: 13 · 2013: 20 · 2012: 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurosurgery (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Keywords
- low-grade glioma, WHO grade II glioma, tumor growth rate, quantitative MRI, tumor volume, 1p/19q codeletion, p53 overexpression, pregnancy, prognosis, progression-free survival, overall survival, treatment response assessment
- MeSH terms
- Glioma, Humans, Magnetic Resonance Imaging, Prognosis, Supratentorial Neoplasms, Disease Progression, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma: A Plea for Systematic Measurement of Growth Rates. https://app.cochat.ai/papers/10.1227/neu.0b013e31826213de
- The paper
- Pallud, J., Taillandier, L., Capelle, L., Fontaine, D., Peyre, M., Ducray, F., Duffau, H., & Mandonnet, E. (2012). Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma: A Plea for Systematic Measurement of Growth Rates. Neurosurgery. https://doi.org/10.1227/neu.0b013e31826213de
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.